434 related articles for article (PubMed ID: 19117993)
1. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of BRCA1-BARD1 ubiquitin ligase by CDK2.
Hayami R; Sato K; Wu W; Nishikawa T; Hiroi J; Ohtani-Kaneko R; Fukuda M; Ohta T
Cancer Res; 2005 Jan; 65(1):6-10. PubMed ID: 15665273
[TBL] [Abstract][Full Text] [Related]
3. Functional Link between BRCA1 and BAP1 through Histone H2A, Heterochromatin and DNA Damage Response.
Fukuda T; Tsuruga T; Kuroda T; Nishikawa H; Ohta T
Curr Cancer Drug Targets; 2016; 16(2):101-9. PubMed ID: 26517537
[TBL] [Abstract][Full Text] [Related]
4. Negative feedback loop of BRCA1-BARD1 ubiquitin ligase on estrogen receptor alpha stability and activity antagonized by cancer-associated isoform of BARD1.
Dizin E; Irminger-Finger I
Int J Biochem Cell Biol; 2010 May; 42(5):693-700. PubMed ID: 20060929
[TBL] [Abstract][Full Text] [Related]
5. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by the platinum-based anticancer drugs.
Atipairin A; Canyuk B; Ratanaphan A
Breast Cancer Res Treat; 2011 Feb; 126(1):203-9. PubMed ID: 20878461
[TBL] [Abstract][Full Text] [Related]
6. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation.
Hashizume R; Fukuda M; Maeda I; Nishikawa H; Oyake D; Yabuki Y; Ogata H; Ohta T
J Biol Chem; 2001 May; 276(18):14537-40. PubMed ID: 11278247
[TBL] [Abstract][Full Text] [Related]
7. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains.
Mallery DL; Vandenberg CJ; Hiom K
EMBO J; 2002 Dec; 21(24):6755-62. PubMed ID: 12485996
[TBL] [Abstract][Full Text] [Related]
8. Tuning BRCA1 and BARD1 activity to investigate RING ubiquitin ligase mechanisms.
Stewart MD; Duncan ED; Coronado E; DaRosa PA; Pruneda JN; Brzovic PS; Klevit RE
Protein Sci; 2017 Mar; 26(3):475-483. PubMed ID: 27977889
[TBL] [Abstract][Full Text] [Related]
9. BRCA1 DNA-binding activity is stimulated by BARD1.
Simons AM; Horwitz AA; Starita LM; Griffin K; Williams RS; Glover JN; Parvin JD
Cancer Res; 2006 Feb; 66(4):2012-8. PubMed ID: 16489000
[TBL] [Abstract][Full Text] [Related]
10. BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.
Morris JR; Solomon E
Hum Mol Genet; 2004 Apr; 13(8):807-17. PubMed ID: 14976165
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric and mutational analyses reveal Lys-6-linked polyubiquitin chains catalyzed by BRCA1-BARD1 ubiquitin ligase.
Nishikawa H; Ooka S; Sato K; Arima K; Okamoto J; Klevit RE; Fukuda M; Ohta T
J Biol Chem; 2004 Feb; 279(6):3916-24. PubMed ID: 14638690
[TBL] [Abstract][Full Text] [Related]
12. Nucleophosmin/B23 is a candidate substrate for the BRCA1-BARD1 ubiquitin ligase.
Sato K; Hayami R; Wu W; Nishikawa T; Nishikawa H; Okuda Y; Ogata H; Fukuda M; Ohta T
J Biol Chem; 2004 Jul; 279(30):30919-22. PubMed ID: 15184379
[TBL] [Abstract][Full Text] [Related]
13. BARD1 is necessary for ubiquitylation of nucleosomal histone H2A and for transcriptional regulation of estrogen metabolism genes.
Stewart MD; Zelin E; Dhall A; Walsh T; Upadhyay E; Corn JE; Chatterjee C; King MC; Klevit RE
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):1316-1321. PubMed ID: 29367421
[TBL] [Abstract][Full Text] [Related]
14. Autoubiquitination of the BRCA1*BARD1 RING ubiquitin ligase.
Chen A; Kleiman FE; Manley JL; Ouchi T; Pan ZQ
J Biol Chem; 2002 Jun; 277(24):22085-92. PubMed ID: 11927591
[TBL] [Abstract][Full Text] [Related]
15. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex.
Kim HS; Li H; Cevher M; Parmelee A; Fonseca D; Kleiman FE; Lee SB
Cancer Res; 2006 May; 66(9):4561-5. PubMed ID: 16651405
[TBL] [Abstract][Full Text] [Related]
16. The UBXN1 protein associates with autoubiquitinated forms of the BRCA1 tumor suppressor and inhibits its enzymatic function.
Wu-Baer F; Ludwig T; Baer R
Mol Cell Biol; 2010 Jun; 30(11):2787-98. PubMed ID: 20351172
[TBL] [Abstract][Full Text] [Related]
17. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function.
Sankaran S; Starita LM; Simons AM; Parvin JD
Cancer Res; 2006 Apr; 66(8):4100-7. PubMed ID: 16618730
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of BRCA1-BARD1 nucleosome recognition and ubiquitylation.
Hu Q; Botuyan MV; Zhao D; Cui G; Mer E; Mer G
Nature; 2021 Aug; 596(7872):438-443. PubMed ID: 34321665
[TBL] [Abstract][Full Text] [Related]
19. BRCA1-independent ubiquitination of FANCD2.
Vandenberg CJ; Gergely F; Ong CY; Pace P; Mallery DL; Hiom K; Patel KJ
Mol Cell; 2003 Jul; 12(1):247-54. PubMed ID: 12887909
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein.
Xia Y; Pao GM; Chen HW; Verma IM; Hunter T
J Biol Chem; 2003 Feb; 278(7):5255-63. PubMed ID: 12431996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]